Over a billion and a half venture dollars poured into the digital health space in Q3 2019. MobiHealthNews recorded 66 deals adding up to roughly $1.55 billion globally — less than half of the $3.3 billion recorded during the same period last year. Babylon Health, a UK-based digital chatbot that also links up to provider practices, topped the charts this quarter with a $550 million funding round led by the Saudi Arabian government. Digital pharmacy Capsule and home testing kit Healthy.io rounded off the top three funding deals.
Rock Health also released its funding report this week tallying $1.3 billion in funding, a cooling compared to the roughly $2 billion quarters it recorded earlier in the year. The difference between these numbers and ours is attributed to the definitions of what counts as a digital health company, and whether or not international companies were tracked.
Read on for a list of the deals in order of size, and click on each company's name for a look back at MobiHealthNews' coverage.
| Company | Round/Series | Amount (M) | Investors | What's it for | What they do |
|---|---|---|---|---|---|
| Babylon Health | Series C | $550.00 | Saudi Arabian crown prince, Tencent, Samsung, Telus, Prudential Asia | This investment is part of Babylon Health's recent fundraising to expand in North America, the Middle East and China. | Babylon's app lets patients book virtual GP appointments and order prescriptions in order to make healthcare more accessible. |
| Capsule | Series C | $200.00 | TCV, Thrive Capital and Glade Brook Capital | The startup plans to put the new cash towards building its New York services and expanding to other locations. | The digital pharmacy company offers hand-delivered same-day medication drop off to its customers. |
| Healthy.io | Series C | $60.00 | Corner Ventures, Joy Capital Ventures, Ansonia Holdings, Aleph and Samsung NEXT | Healthy.io is accelerating global expansion and continue product development. Additionally, the company plans to pursue additional regulatory approvals so that its new ACR test can be used at home as well. | Healthy.io's primary product is Dip.io, a smartphone-enabled testing kit consisting of a disposable test strip, testing cups and a colored panel. Strips are dipped into urine samples and then placed into the board, whereupon the user takes a picture of the two with their smartphone camera to receive a prompt result. |
| Nurx | Series C | $52.00 | Kleiner Perkins Digital Growth Fund, Union Square Ventures, Reproductive Health Investors Alliance, Dreamers VC (actor Will Smith's venture fund), Lowercase Capital, and Y Combinator | The company has a lot of plans for this funding, including introducing additional offerings for what they describe as "sensitive health needs" and growing their userbase. | Nurx offers telemedicine prescription and delivery of birth control pills. |
| OneDrop | Series B | $40.00 | Bayer | While the company didn't spell out exactly how they will be using the $40 million, its new deal with Bayer includes helping the pharma build up its digital efforts in oncology, cardiovascular diseases and women's health. | OneDrop uses artificial intelligence to make lifestyle recommendations to people with chronic conditions. |
| Synyi | Series C | $36.30 | Tencent, Sinopharm Capital | Synyi will use the latest funds to explore the smart healthcare sector, attract new medical and AI talent and ensure its products stay at the top of the Chinese market. | To solve the problem of data silos and low usability of data in healthcare information systems, Synyi developed a new hospital informatics platform with AI capabilities in 2018. |
| Exo | $35.00 | Intel Capital, Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments | The new money will be put towards developing the product and helping the startup go through regulatory channels. | The Redwood City, California-based startup is developing a portable ultrasound that is able to create a 3D image. | |
| Ginger | Series C | $35.00 | WP Global Partners, City Light Capital, Nimble Ventures, LinkedIn CEO Jeff Weiner, Khosla Ventures, Kaiser Permanente Ventures and Kapor Capital | The new money will go toward growing its data sciences and clinical services. It is planning to expand globally within the next two years. | Ginger focuses on providing digital mental health services including behavior health coaching, video therapy, tele-psychiatry visits and other self-guided content. |
| Amboxx | Series B | $32.90 | Partech's growth fund, Cherry Ventures, Wellington Partners and Holtzbrinck Digital | The new funds will go toward developing clinical decision support tools for specialists and generalists. | Amboss was developed as a digital resource to help medical students and professionals access information. The platform includes a program specifically designed help medical students study for the US medical licensing exams and national board exams. |
| Huimei Healthcare | Series C | $30.00 | Qiming Ventures and WuXi AppTech | The funds will be used by the company to develop its core-product, as well as for further product R&D. | Huimei Healthcare's core product is an AI-based clinical decision support system called Dr. Mayson. |
| Calm | Series B | $27.00 | Lightspeed Venture Partners | The comapny did not outline plans but previously discussed international growth. | Calm is mainly a meditation app. It has added new features to include a breathing coach and tools for helping users fall asleep. |
| MDClone | Series B | $26.00 | aMoon, OrbiMed Israel Partners and Lightspeed Venture Partners | The company will use the funds to further develop its existing platform, build new products and accelerate growth. | MDClone's engine examines original patient data and generates new datasets based only on statistical data, containing no information that would risk exposing patient identity. |
| BrightInsight | Series A | $25.00 | New Leaf Venture Partners and Eclipse Ventures | This new round will help the company beef up the functionality of its platform as well as its commercialization efforts. In addition, BrightInsight is seeking to further its integration with EHRs, payers and disease management platforms. | BrightInsight — part of electronics manufacturing services firm Flex —sees itself acting as the infrastructure of a digital health ecosystem. Its Internet of Things platform brings together assorted digital health products and services so that provider, biopharma or other healthcare organizations can more easily manage their data. |
| Vim | Series B | $24.00 | Optum Ventures, Premera Blue Cross, Great Point Ventures, Sequoia Capital and Leverage Health Solutions | The new funding will support the company's growth as it enters new markets within the US. It also plans to scale up its product development and hiring initiatives. | Vim offers a patient-facing appointment booking platform that can be integrated onto payer and provider sites or apps. |
| GNS Healthcare | Series D | $23.00 | Cigna Ventures, Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman, the former CEO of Caesar and division president of Aetna | While the startup didn't spell out its exact intentions for the money in the future, it did indicate that it would be working with Cigna and others to continue personalized health iniatives. | The company's platform, dubbed REFS (Reverse Engineering and Forward Simulation), is able to collect multiple data points — including a patient's EHR data, lab results, genomic data, and prescription data — and in turn help pinpoint relationships between outcomes and treatment. |
| Kheiron Medical Technologies | Series A | $22.00 | Atomico, Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds | Kheiron plans to use the new funding to carry out further clinical trials of Mia in Europe, the US and Asia in order to "rigorously assess and demonstrate the clinical effectiveness and safety of the software," according to a press announcement. | Kheiron's Mammography Intelligent Assessment is designed to analyse standard full-field digital mammography (FFDM) images in a breast cancer screening setting and support radiologists in making the clinical decision to recall a patient for further investigation or not. |
| Nomad Health | N/A | $20.37 | Icon Ventures with participation from Polaris Partners, RRE Ventures, .406 Ventures and Silicon Valley Bank | The startup has pledged to use the new funds to double its staff and build out its technology. | The company's digital platform aims to connect qualified doctors and nurses to provider organizations looking for new staff. |
| Eko | Series B | $20.00 | ARTIS Ventures, DigiTx Partners, NTT Venture Capital (NTTVC), 3M Ventures, Mayo Clinic, Seaph Group and XTX Ventures | These new funds with support additional R&D and commercialization of its machine learning platform. | The San Francisco company is perhaps best known for its Eko Duo device, a smart remote monitor that's part stethoscope, part ECG. However, the company has lately had a hand in the clinical trial space as well, having launched a new platform in July called Eko Home that looks to pinpoint novel drug-data combinations. |
| inveox | N/A | $18.50 | N/A | The company did not disclose how the new money would be used. | inveox is the maker of an AI-enabled system developed to digitize processes in pathology laboratories. |
| Pivot | Series A | $17.00 | DCM, Bling Capital, Founders Fund, Khosla Ventures, Signal Fire and Y-Combinator | It will be using the funds to bulk up its engineering and operations teams. | Pivot's platform is a combination hardware and software service offering consisting of weights, a heart rate monitor, a connected mobile app and 3D sensors that use machine learning to track the user's movements. |
| Luma Health | Series B | $16.00 | PeakSpan Capital, Cisco Investments, Texas Medical Center and US Venture Partners | Luma plans to target larger customer organizations and hire new staff that could build out new patient acquisition and retention features for the platform. | Luma's "end-to-end patient journey automation platform" is an EHR-friendly tool that eases patients into care while automating their booking and scheduling needs. The text-driven tool automatically reaches out to patients with appointment reminders, referral management, insurance data validation or general post-procedure check ins, while updating supported EHR or scheduling systems accordingly. |
| Maple | N/A | $14.50 | Acton Capital and SE Health | Maple is looking to grow its services in Canada over the next two years, and said the new funds will help enable this. | Maple is a traditional virtual care company that connects patients to doctors through a telemedicine platform. |
| Belong.Life | Series B | $14.00 | IQVIA, The Group Ventures and the startup's existing vendors | The new funding will be used to expand its social network app and patient engagement platform. | The company's free Belong app allows patients with cancer or those caring for them to connect with and support others undergoing treatment for dozens of different cancers. |
| Hello Heart | Series B | $12.00 | Khosla Ventures, BlueRun Ventures, Maven Ventures and Resolute Ventures | The money will be put towards expanding and scaling its team. | Hello Heart's bread and butter is its app-driven platform for hypertension, blood pressure and general cardiovascular health management. |
| Robin Healthcare | Series A | $11.50 | Northwest Venture Partners | Robin will put the new money towards developing its product and building relationships with more provider organizations. | Robin's device, which looks similar to an Amazon Alexa or Google Home voice assistant, will sit in a doctor's office and draft notes from clinicians' spoken conversations. The voice-enabled AI device is designed to help doctors and clinicians write clinical notes. |
| Firefly Health | Series A | $10.20 | F-Prime Capital and Oak HC/FT | While the company has not specified how the new money will be used, it did say that it plans to enter several new markets in 2020. | The platform helps connect members and medical service, whether that be in-person or digitally. Patients are able to see a provider in person, through video visits or via in-app chat, and manage prescription refills. |
| Mednition | Series A | $10.00 | Concord Health Partners | Proceeds from the financing will be used to expand the company's customer care team as Mednition further scales commercial deployment of KATE. | Starting initially in the emergency department, Mednition is providing emergency nurses with KATE, a machine learning clinical decision support solution now in use at Adventist Health White Memorial in Los Angeles. |
| InsightRX | Series A | $10.00 | HealthX Ventures, Rock Health, OSF Healthcare, Leawood Venture Capital, GreatPoint Ventures and Premier Inc. | This latest funding will help InsightRX push its platform into new therapeutic areas and improve system integrations. The company is also looking to expand its reach within the provider and pharmaceutical markets. | InsightRX has built a software platform that relies on EHR data to develop individualized medication dosing regiments. Called InsightRX Nova, physicians can employ the tool at the bedside to assist with treatments for more than 100 drug-assisted therapeutic areas. |
| Myia Labs | Series A | $10.00 | Mercy Virtual, etta Venture Partners, BootstrapLabs, Boston Consulting Group and B Capital Group | This new investment will help it scale hiring efforts, particularly for roles relating to data science and mathematics, security and regulatory affairs. In addition, the funds will also fuel the product's expansion from its initial focus on congestive heart failure to other chronic conditions such as COPD, Type 2 diabetes and hypertension. | Myia's platform uses Apple Watches, Fitbits, Oura Rings and other consumer devices with monitoring capabilities to collect real-world patient data. These are combined with the company's applied machine intelligence tech to generate insights on these patients' chronic conditions. |
| Health Recovery Solutions | N/A | $10.00 | Edison Partners | HRS did not outline any specific focuses for its business in the announcement. | HRS offers a broad range of telehealth services that provide systems with real-time monitoring, virtual visits, messaging, patient engagement and education, image transfer and other remote care features. |
| CareVoice | Series A | $10.00 | LUN Partners Group, unnamed fintech fund, DNA Capital, SoSV and Artesian Capital | CareVoice is investing in platform R&D, expanding its sales teams and launching 10 new health insurtech products. | CareVoice partners with insurers to provide a mobile-based, SaaS cost comparison tool to insurance plans' members. |
| MyHealthTeams | Series B | $9.44 | Adams Street Partners, Qiming US Ventures, CVS Health, The Westly Group, HealthTech Capital and 500 Startups | The new money will be put toward growing the network and expanding the platform. | MyHealthTeams is a social network designed to help patients with chronic conditions share resources and connect. |
| Tivic Health Systems | seed funding | $8.00 | Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital and Skylight Investments | The new money will fuel a marketing push for the ClearUP device's upcoming launch. | Tivic's primary product, the ClearUP Sinus Pain Relief device, is a non-invasive, over-the-counter treatment for hay fever sinus pains. |
| Kaia Health | Series A/B | $8.00 | Optum Ventures | The new money will be put towards developing and scaling the technology. | Kaia Health got its start with a digital physical therapy platform for back pain, which guides users through exercises at home. However, it has quickly expanded to include everything from exercise and wellness tools to programs aimed at treating COPD symptoms. |
| FIGUR8 | Seed funding | $7.50 | P5 Health Ventures and E14 Fund | The new funding will be put towards supporting the technology's launch. | FIGUR8's digital platform is designed to measure and track body movements as a biomarker. |
| Thriva | Series A | $7.30 | Pembroke VCT and Guinness Asset Management | The company did not specify how they would use the money. | Thrivia is a London-based platform providing mail-order blood tests for consumers. |
| DEARhealth | Series A | $6.80 | Philips Health Technology Ventures, Vesalius Bio Capital lll and Health Innovations | The new money will be used to help expand its service in Europe and open its European headquarters in Amsterdam. | DEARhealth's technology uses AI to help clinicians come up with a care plan for patients. The platform is able to integrate with EHR systems and pinpoint subpopulations for specific care. |
| PeerWell | Series A | $6.50 | OMERS Ventures and Xseed Capital | The money will be put towards launching the company's new compensation surgery optimization platform. | Before a surgery, patients can log in to PeerWell's PreHab, a pre-surgery platform that gives patients lessons and advice about their condition. After surgery patients can access ReHab, which helps supplement in-person physical therapy sessions and gives patients additional information about their condition. |
| Pops! Diabetes Care | Series A | $6.00 | 30Ventures, Rise of the Rest Seed Fund and Flying Point Industries | The company said the new cash will go towards commercializing the Pops! one System. | Pops! Diabetes Care makes a smart glucometer that employs an algorithm to give users real-time personalized diabetes coaching. |
| Baze | Series A | $6.00 | Nature's Way | Baze plans to build out its marketing to promote the benefits of individualized nutritional supplements among consumers. | Baze is a subscription platform that ships personalized vitamin supplement packages. |
| Wave | seed funding | $5.65 | CrossLink Capital, Lerer Hippeau Ventures, Collaborative Fund and Ludlow Ventures | The company did not outline specific plans. | Wave is a subscription app and connected foam cushion for at-home meditation. |
| Dadi | investment funding | $5.00 | TCG, Capital and Third Kind Ventures | The new funding will help expand its customer services capabilities, which include more fertility education and customer support. | Dadi is a direct-to-consumer male fertility testing and sperm storage startup. |
| MedAnswers | $5.00 | Special Situations' Life Sciences Innovation (LSI) Fund and Viking Global Investors | The new money will be used to continue the rollout of FertilityAnswers. | The company's product FertilityAnswers emulates a social media feed, but its goal is to help consumers trying to conceive view clinically validated expert information. | |
| Fitplan | N/A | $4.50 | Corazon Capital, A-Rod Corp, Mark Mastrov, Lerer Hippeau, Bullpen Capital, Imaginary and Advancit Capital | The new funding will go toward further development of the product, and will help Fitplan bring more athletes onto its roster of featured trainers. | The Fitplan app delivers on-demand video workout sessions and exercise tracking to consumers for a monthly or annual subscription. These sessions are headed by one of the company's dozens of fitness coaches. |
| Aural Analytics | Seed funding | $4.30 | Morningside Ventures, Tamarisc Ventures, Six Street Partners Group managing director Jamie Gates, Marc Abramowitz, Arizona Tech Investors and Desert Angels | These funds will help the company expand its clinical trial platform, as well as release an integration portal for speech collection and analysis alongside other clinical-grade mobile and web products. | The AI engine collects speech samples through a smartphone or tablet app, and uploads these to a cloud server for analysis. From these, the company can generate insights on the speaker's neurological health, such as Alzheimer's disease. |
| NexHealth | N/A | $4.20 | Point Nine Capital, Rubicon Venture Capital, Scott Belsky, Josh Hannah and iSeed Ventures | Alongside improvements to its product, NexHealth is opening a new office in San Francisco, and as such will be using some of these new funds to staff its new west coast location. | NexHealth offers a tool that helps practices mange their communications and administrative interactions with patients. |
| Genneve | N/A | $4.00 | BlueRun Ventures. Maven Ventures and Startup Health | The company will be using its new funding to expand its service from 23 states to 50 by the end of the year. | Genneve provides an online telehealth service serving women experiencing menopause. |
| metaMe Health | seed funding | $3.80 | LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers | The seed funding will support continued development of the digital product, particularly through the initiation of a large, randomized controlled trial of IBS patients. | The startup creates behavioral digital treatments for gastrointestinal conditions. |
| Mahmee | N/A | $3.00 | ArlanWasHere Investments, Mark Cuban, Serena Williams' Serena Ventures and Revolution's Rise of the Rest Seed Fund | Mahmee will focus on building its team of engineers, clinicians and salespeople using its new money. | Mahmee's tool works within a provider's IT system to link a mother and child's health records and help keep the care team coordinated. |
| NextStep | N/A | $3.00 | SEI Ventures, JAZZ Venture Partners, Learn Capital's Learn Start Fund, Springrock Ventures, City Light Capital, Frontier Angels and managing directors from Pioneer Square Labs | The company did not specify what the new funds will be put towards. | The Seattle, Washington-based startup focuses on digitally training new healthcare workers, in particular individuals who have lost their jobs because of new technology. |
| Karuna Labs | Seed funding | $3.00 | Baseline Ventures, Anorak Ventures, the AET Fund, the Hustle Fund, Correlation Ventures and Dreamit Ventures | Karuna said that this funding will support clinical validation studies of its VR product, and help the company further develop its technology and staff. | The company develops personalized VR programs for chronic pain management. The tool uses a technique known as "virtual embodiment training" to help users disassociate body motions with pain. |
| Zero | seed funding | $2.80 | True Ventures and Trinity Ventures | The company said it plans to use the new funds to grow the platform and bring new product offerings to market. | The company's app is centered around helping users bring fasting into their dietary regime. |
| Voro | Seed funding | $2.50 | Floodgate, Techstars, Flatiron Health, Tilt, Clover Health, Surion, Teamworthy Ventures, AVG Basecamp Fund, Ride Ventures, OneOncology and others | The startup did not outline any specific uses for its seed funding. | Voro's "health care social network" looks to inform patients' care decisions by providing them with direct recommendations from their friends, coworkers or neighbors. |
| BabySparks | seed funding | $2.00 | Miami Angels, Kairos, Marstar Investments, Lou Kreisberg and Steve Goodman | The startup plans to use the funds to accelerate and grow the product. | BabySparks has built an app-based tool for parents to track and stimulate the development of their young children. |
| TNH Health | Series A | $2.00 | Valor Capital Group and unnamed individual entrepreneurs | The new money will go towards promoting the chatbot, as well as expanding internationally to the US. | The startup is focusing on mental health conditions such as anxiety, stress and depression via a chatbot runs in Facebook Messenger, Whatsapp, web channels, SMS and mobile platforms. |
| Wefight | N/A | $1.98 | Funds secured through the EIT Health Investor Network | Wefight plans to extend its product to a further 33 disease types by 2020. | Wefight's 'Vik' app can answer patients' questions about their condition, treatment and care pathway. It features services such as smart pill reminders, a notebook to monitor side effects and personalized therapeutic education. |
| Shleep | N/A | $1.54 | Global Founders Capital and Health Innovations | The funding will help Shleep scale its platform. | With Shleep's digital sleep coaching platform, users get access to a "sleep expert," courses, relaxation tools and individual and group consultations, as well as live webinars providing information on how to cope with sleep deprivation and insomnia, among others. |
| Flow | N/A | $1.50 | Khosla Ventures | The new funding will be put toward rolling out the product in Europe. | Flow is a two-part system including a brain stimulation headset and a therapy app. |
| Vine Health | seed funding | $1.47 | Playfair Capital | The new cash will be put towards growing the team and developing the platform. | The company's aim is to help cancer patients manage their condition and symptoms through an app. |
| Enable My Child | Seed funding | $1.20 | CMI Ventures | The money will help Enable My Child expand its virtual services for school and early intervention centers across the country. | The company is focused on connecting children with behavioral, learning or developmental conditions to a variety of board-certified therapists for tele-therapy. The services include virtual occupational therapy, speech therapy, physical therapy and psychology services. |
| UpLift Health | seed funding | $1.00 | Laidir Foundation | The recent investment will be put towards developing the company's technology. | The Atlanta-based startup has created an app that employs cognitive behavioral therapy (CBT) to help users with depression. |
| RocketBody | N/A | $1.00 | Gagarin Capital and AltaIR Capital | The new funds will be used to improve user retention and hammer out the monetization of its app. | RocketBody has released an Apple Watch app that uses the onboard ECG sensor and AI to guide fitness and training recommendations. |
| SafeKeeping | Seed funding | $0.33 | Solidea Capital and other unnamed investors | The funding will allows SafeKeeping to expand its team, platform and client reach. | SafeKeeping's integrated communication tool aims to cut down on non-emergency calls between care teams and patient families. |
| Mightier | Series A | $0.25 | Modern Time Group | The new money and partnership with MTG will go towards adding more tools for users. | Mightier's program includes 25 bioresponsive mobile games and a special heart rate monitoring band. The games are aimed at help children learn coping skills like deep breathing and visualization. |
| Mika | N/A | undisclosed | Ananda Impact Ventures and VC Fonds Technologie Berlin | The funds will support a clinical study and further app development. | Mika has developed an app to support cancer patients and their families, in collaboration with the Charité university hospital in Berlin and University Hospital Leipzig. |
| Echelon Fitness Multimedia | N/A | N/A | North Castle Partners | The investment will help Echelon Fit increase the availability of its existing and upcoming products in North America. | The startup offers an in-home connected workout experience similar to Peloton; however, customers can connect the bike to their own tablet. |
